Benchling

Executive Summary

Benchling provides a cloud-based platform specifically designed for biotechnology research and development, acting as a digital system of record for scientists. The company replaces legacy paper notebooks and generic spreadsheets with specialized tools for DNA sequencing, sample tracking, and workflow management. Benchling has seen its annual recurring revenue grow significantly as pharmaceutical giants like Gilead and Sanofi adopt its platform to accelerate drug discovery. Financially, the company has focused on expanding its enterprise footprint while maintaining a high net revenue retention rate above 120%. Its primary strength lies in being the 'operating system' for the biotech industry, though its growth is tied to the overall health of life science funding. This IPO will be a significant indicator of the market's appetite for vertical SaaS companies serving complex scientific sectors.